Παρακολούθηση
Sonia Liggi
Sonia Liggi
Healx
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα healx.io
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ...
Cell 185 (3), 467-484. e15, 2022
8932022
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7122021
Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients
ML Santoru, C Piras, A Murgia, V Palmas, T Camboni, S Liggi, I Ibba, ...
Scientific reports 7 (1), 9523, 2017
3252017
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
TM Drake, AM Riad, CJ Fairfield, C Egan, SR Knight, R Pius, ...
The Lancet 398 (10296), 223-237, 2021
1422021
The potential of Ion Mobility Mass Spectrometry for high-throughput and high-resolution lipidomics
C Hinz, S Liggi, JL Griffin
Current opinion in chemical biology 42, 42-50, 2018
1042018
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
TI de Silva, G Liu, BB Lindsey, D Dong, SC Moore, NS Hsu, D Shah, ...
Iscience 24 (11), 2021
622021
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
F Liew, S Talwar, A Cross, BJ Willett, S Scott, N Logan, MK Siggins, ...
EBioMedicine 87, 2023
582023
KniMet: A pipeline for the processing of chromatography–mass spectrometry metabolomics data
S Liggi, C Hinz, Z Hall, ML Santoru, S Poddighe, J Fjeldsted, L Atzori, ...
Metabolomics 14, 1-4, 2018
522018
A comprehensive UHPLC ion mobility quadrupole time-of-flight method for profiling and quantification of eicosanoids, other oxylipins, and fatty acids
C Hinz, S Liggi, G Mocciaro, S Jung, I Induruwa, M Pereira, CE Bryant, ...
Analytical chemistry 91 (13), 8025-8035, 2019
512019
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis
S Poddighe, F Murgia, L Lorefice, S Liggi, E Cocco, MG Marrosu, L Atzori
The international journal of biochemistry & cell biology 93, 148-155, 2017
502017
Italian cohort of patients affected by inflammatory bowel disease is characterised by variation in glycerophospholipid, free fatty acids and amino acid levels
A Murgia, C Hinz, S Liggi, J Denes, Z Hall, J West, ML Santoru, C Piras, ...
Metabolomics 14, 1-14, 2018
482018
Anti-cancer drug development: computational strategies to identify and target proteins involved in cancer metabolism
L Mak, S Liggi, L Tan, K Kusonmano, J M Rollinger, A Koutsoukas, ...
Current pharmaceutical design 19 (4), 532-577, 2013
452013
Metabolomics applied to diabetes− lessons from human population studies
S Liggi, JL Griffin
The international journal of biochemistry & cell biology 93, 136-147, 2017
422017
Connecting gene expression data from connectivity map and in silico target predictions for small molecule mechanism-of-action analysis
AC Ravindranath, N Perualila-Tan, A Kasim, G Drakakis, S Liggi, ...
Molecular BioSystems, 2014
392014
A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans
E Charidemou, T Ashmore, X Li, BD McNally, JA West, S Liggi, M Harvey, ...
JCI Insight, 2019
342019
Extending in silico mechanism-of-action analysis by annotating targets with pathways: application to cellular cytotoxicity readouts
S Liggi, G Drakakis, A Koutsoukas, I Cortes–Ciriano, P Martínez–Alonso, ...
Future Medicinal Chemistry 6 (18), 2029-2056, 2014
322014
Metabolomic profile in hyperthyroid patients before and after antithyroid drug treatment: Correlation with thyroid hormone and TSH concentration
C Piras, N Arisci, S Poddighe, S Liggi, S Mariotti, L Atzori
The International Journal of Biochemistry & Cell Biology 93, 119-128, 2017
302017
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study
F Närhi, SR Moonesinghe, SD Shenkin, TM Drake, RH Mulholland, ...
The Lancet Digital Health 4 (4), e220-e234, 2022
262022
Extensions to In Silico Bioactivity Predictions Using Pathway Annotations and Differential Pharmacology Analysis: Application to Xenopus laevis Phenotypic …
S Liggi, G Drakakis, AE Hendry, KM Hanson, SC Brewerton, GN Wheeler, ...
Molecular Informatics 32 (11‐12), 1009-1024, 2013
262013
Using Molecular Initiating Events to generate 2D structure–activity relationships for toxicity screening
TEH Allen, S Liggi, JM Goodman, S Gutsell, PJ Russell
Chemical Research in Toxicology 29 (10), 1611-1627, 2016
192016
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20